Garcia was found to have ostarine in his system before and after beating Devin Haney on April 20. Ryan Garcia is experiencing a horrific start to 2024 after a series of bizarre social media posts, ...
Apalutamide with androgen deprivation therapy following radical prostatectomy led to a biochemical recurrence-free survival rate of 100% after 2 years among patients with high-risk prostate cancer.
Hormonal classes could divide athletes according to the sex biology that matters — increasing fairness while avoiding ...
For patients with locally advanced prostate cancer, neoadjuvant chemohormonal therapy (NCHT) is beneficial for biochemical progression-free survival (bPFS), according to a study published online May 1 ...
The follow-on analysis of results from the phase 3 PSMAfore study, along with the overall study results, support the ...
Patients with high-risk prostate cancer who had a higher dose of radiation plus long-term androgen deprivation therapy tended to live longer than those who had a lower dose. Patients with metastatic ...
Calcium and vitamin D supplement use was linked to a lower risk for cancer mortality but a higher risk for cardiovascular disease mortality among postmenopausal women. Calcium and vitamin D ...
Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK We describe the ...
Androgens promote differentiation of mesenchymal multipotent cells into the myogenic lineage and inhibit their adipogenic differentiation, by facilitating association of androgen receptors with β ...
Bipolar androgen therapy (BAT) is the cyclical administration of supraphysiological androgen (SPA), which can be an effective treatment for 30-40% of patients with castration-resistant prostate cancer ...
Markowski, MD, PhD. In this interview, Mark C. Markowski, MD, PhD, discusses bipolar androgen therapy (BAT), including its advantages and disadvantages, trials that have evaluated the treatment, and ...